WCG PharmaSeek Is Now the WCG Site Network

Connecting the Clinical Trial Ecosystem. Bringing Clinical Trials to Community Physicians and Their Patients. 

Princeton, NJ – March 21, 2022 – WCG’s vision is to provide seamless connectivity across the clinical trial ecosystem, enabling more physicians, and their patients, to have more opportunities to participate in clinical trials while enabling best-in-class services and supportive technologies. WCG is pleased to announce that WCG PharmaSeek will now be known as the WCG Site Network.

The Journey

For more than 25 years, WCG PharmaSeek has successfully partnered with sponsors and CROs to identify potential research sites for industry-sponsored Phase I-IV clinical trials. Initially comprised of 12 Midwestern research sites, the group soon blossomed into a network of 350+ investigative sites and 1,100+ principal investigators throughout the United States and Puerto Rico.

In 2019, PharmaSeek joined WCG, gaining new opportunities to benefit sites, sponsors, and CROs. The WCG Site Network assists investigational sites with clinical trial administrative and back-office services that enable them to focus on the activities that matter most to them – seeing and treating patients. We support sites via study acquisition, financial management, study start-up, study advertising, and more.

The Future

Lindsay McCarthy, Vice President, WCG Site Network, says, “We are now pleased to be known as the WCG Site Network. This network includes expert independent research facilities, multi-specialty practices, urgent care centers, and community hospitals. We’re serving sites that see 85% of patients, but only 15% of industry trials.¹ Our affiliated sites practice research in virtually every therapeutic area, including oncology, central nervous system (CNS), vaccine, neurology, and more. Within the last three years, we have facilitated the execution of over 600 Clinical Trial Agreements, supporting 9 of the top 10 industry CROs and 7 of the top 10 industry sponsors.

Moving forward, our commitment to our sites, sponsors, and CROs remains strong. Because of the ever-changing landscape of the site space, we have realized the importance of creating a solid foundation to conduct clinical research while enabling physicians to reach patients in their own communities.​ Our foundation is built on providing sites access to more clinical trials, tools, and resources that educate and support physicians and coordinators on the administrative functions of clinical research. This positions sites within the WCG Site Network to be top performers, from both a quality and enrollment standpoint. Our goal is to enable sites to reach their full potential by growing their study pipeline, patient base, and research program as they transform patient care. In 2022, sites in our network can also expect to receive access to Clinical Research Coordinator, Principal Investigator, and Good Clinical Practice training on-demand with cross-company certifications, which will allow them to further increase quality and reduce site training costs.

This is just the first of many exciting things in store to further support our clients in 2022. With near-term plans to grow the number of sites in key therapeutic areas, add additional services to further expedite study start-up, and build enrollment solutions focused on diversity and representation. For sites, this means developing a scalable research program through study identification, contract and budget negotiation support, study advertising, access to training, and other support. For sponsors and CROs, it means access to high-performing sites in virtually every therapeutic area, access to new patient populations, and a streamlined study start-up process. At the end of the day, our goal is to help more patients to get access to new treatments faster.”

To learn more about the WCG Site Network, visit our website.

References:

1. Tufts: https://academic.oup.com/jnci/article/111/3/245/5307078